Chronic kidney disease (CKD) can feel confusing, especially when you’re told you’re in “stage 3” but then hear there are actually two versions: stage 3A and stage 3B. That split exists for an important reason—and understanding it can help you make better decisions about your health, medications, and long-term outlook.

This guide breaks everything down in simple terms: what stage 3 CKD really means, how 3A and 3B differ, what your lab numbers are telling you, what symptoms to watch for, and why doctors treat these two stages differently.

---

Understanding eGFR (The Most Important Number)

eGFR estimates how well your kidneys filter blood.

• A normal eGFR is about 90 or higher
• Lower numbers mean reduced kidney function

Here’s how CKD stages are classified:

• Stage 1: eGFR ≥ 90 (with kidney damage markers)
• Stage 2: eGFR 60–89
• Stage 3A: eGFR 45–59
• Stage 3B: eGFR 30–44
• Stage 4: eGFR 15–29
• Stage 5: eGFR < 15 (kidney failure)

---

Why Stage 3 Is Split Into 3A and 3B

At first glance, stage 3 might seem like one category. But research showed something important:

People with eGFR below 45 (stage 3B) have:

• Significantly higher complication rates
• Faster disease progression
• Greater cardiovascular risk
• More need for specialist care

Meanwhile, people in stage 3A (45–59) often:

• Remain stable for years
• Have fewer symptoms
• Have lower complication risk

So the split exists to reflect real-world differences in outcomes, not just numbers.

---

Core Differences Between Stage 3A and 3B

1. Kidney Function Level

• Stage 3A: Mild-to-moderate loss
• Stage 3B: Moderate-to-severe loss

This may sound subtle, but it’s a big shift physiologically.

---

2. Risk of Progression

• Stage 3A: Lower risk of progressing to kidney failure
• Stage 3B: Much higher risk of progressing to stage 4 or 5

Doctors take stage 3B more seriously because it’s closer to advanced disease.

---

3. Complication Risk

As kidney function drops, complications increase.

More common in Stage 3B:

• Anemia
• Bone and mineral disorders
• High potassium (hyperkalemia)
• Fluid imbalance
• Acid buildup (metabolic acidosis)

---

4. Monitoring Frequency

• Stage 3A: Labs every 6–12 months (sometimes more often depending on risk)
• Stage 3B: Labs every 3–6 months or closer

---

5. Specialist Involvement

• Stage 3A: Often managed by primary care
• Stage 3B: Frequently referred to a nephrologist (kidney specialist)

---

6. Medication Sensitivity

In stage 3B:

• More medications require dose adjustments
• Some drugs become unsafe (especially NSAIDs, certain antibiotics, contrast dyes)

---

Symptoms: What You Might Feel (or Not Feel)

One tricky part of CKD is that you may not feel symptoms early on.

Stage 3A Symptoms

Often minimal or absent:

• Mild fatigue
• Slight swelling (rare)
• Subtle changes in urination

Many people feel completely normal.

---

Stage 3B Symptoms

More noticeable, but still not always obvious:

• Increased fatigue
• Swelling in legs or ankles
• Changes in urination (frequency, foamy urine)
• Muscle cramps
• Trouble concentrating (“brain fog”)
• Dry or itchy skin

Still, many people remain asymptomatic even in 3B.

---

Lab Values: What Changes Between 3A and 3B

Beyond eGFR, several lab markers begin to shift.

1. Creatinine

• Waste product filtered by kidneys
• Higher in stage 3B than 3A

---

2. BUN (Blood Urea Nitrogen)

• Indicates waste buildup
• Often mildly elevated in 3A, more elevated in 3B

---

3. Potassium

• Stage 3A: Usually normal
• Stage 3B: Risk of high potassium, which can affect the heart

---

4. Hemoglobin (Anemia)

Kidneys produce a hormone (EPO) that helps make red blood cells.

• Stage 3A: Usually normal or slightly low
• Stage 3B: More common anemia → fatigue, weakness

---

5. Calcium & Phosphorus

Kidneys regulate mineral balance.

• Stage 3A: Usually stable
• Stage 3B: Imbalances begin → bone disease risk

---

6. Parathyroid Hormone (PTH)

• Starts rising in stage 3B
• Signals early bone metabolism problems

---

7. Albuminuria (Protein in Urine)

Measured via urine tests:

• Indicates kidney damage
• Important predictor of progression

---

Risk Factors That Matter More in 3B

Certain conditions accelerate decline, especially in stage 3B:

• Diabetes
• High blood pressure
• Heart disease
• Smoking
• Obesity
• High proteinuria

---

Cardiovascular Risk: A Major Difference

CKD is strongly linked to heart disease.

• Stage 3A: Moderate increase in cardiovascular risk
• Stage 3B: Significantly higher risk of heart attack, stroke, and death

In fact, many CKD patients are more likely to develop heart problems than kidney failure.

---

Lifestyle Differences Between 3A and 3B

Diet

Stage 3A:

• Moderate sodium restriction
• Balanced diet

Stage 3B:

• More attention to:
  • Potassium
  • Phosphorus
  • Protein intake

---

Fluid Intake

Usually normal in 3A
May need monitoring in 3B if fluid retention develops

---

Exercise

Recommended in both, but fatigue may limit activity in 3B

---

Medication Management Differences

Stage 3A

• Many medications still safe
• Mild dose adjustments

Stage 3B

• Careful dosing required
• Avoid:
  • NSAIDs (ibuprofen, naproxen)
  • Certain contrast dyes
  • Some antibiotics

Common medications used:

• ACE inhibitors / ARBs (protect kidneys)
• Diuretics
• Statins
• Erythropoiesis-stimulating agents (for anemia in later stages)

---

Prognosis: What to Expect

Stage 3A

• Many people remain stable for years
• Some never progress

Stage 3B

• Higher chance of decline
• May progress to stage 4 over time
• Requires closer management

That said, progression is not guaranteed—many people stabilize with proper care.

---

Why the 45 eGFR Cutoff Matters So Much

The number 45 isn’t arbitrary.

Research shows:

• Complication rates increase sharply below 45
• Hospitalization risk rises
• Mortality risk increases
• Treatment decisions change

So splitting stage 3 helps doctors:

• Intervene earlier
• Prevent complications
• Customize care

---

When Should You See a Nephrologist?

Typically recommended for:

• Stage 3B (eGFR < 45)
• Rapid decline in kidney function
• High protein in urine
• Difficult-to-control blood pressure

---

How to Slow Progression (Both 3A and 3B)

Regardless of stage, these matter:

• Control blood pressure (target often <130/80)
• Manage blood sugar (if diabetic)
• Avoid kidney-harming medications
• Reduce salt intake
• Maintain healthy weight
• Stay active
• Quit smoking

---

Mental and Emotional Impact

CKD can create anxiety, especially when numbers drop.

Stage 3A:

• Often reassurance-focused care

Stage 3B:

• More active disease management → more stress

Understanding your stage helps reduce uncertainty.

---

Full Summary: Stage 3A vs Stage 3B in Plain Terms

Stage 3 CKD is not one uniform condition—it’s split into 3A and 3B because the risks, symptoms, and management differ significantly.

• Stage 3A (eGFR 45–59) is an earlier phase where kidney function is moderately reduced but often stable. Many people have few or no symptoms, and complications are less common.
• Stage 3B (eGFR 30–44) represents a more advanced level of kidney damage. At this point, the risks of complications—like anemia, bone disease, and high potassium—increase noticeably. Patients require closer monitoring, more careful medication management, and often specialist care.

The split exists because people below an eGFR of 45 behave very differently medically than those above it. Outcomes worsen, risks rise, and treatment approaches change.

In simple terms:

• 3A = earlier, lower risk, often stable
• 3B = more advanced, higher risk, needs closer care

Understanding which category you’re in helps guide:

• How often you’re monitored
• What lifestyle changes matter most
• When to involve specialists
• What risks to watch for

The good news is that progression is not inevitable. With proper management, many people—especially in stage 3A—can maintain stable kidney function for years.

---

References & Resources

• National Kidney Foundation (NKF) – CKD Staging and Guidelines
• Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guidelines
• Centers for Disease Control and Prevention (CDC) – Chronic Kidney Disease Overview
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Levey AS et al. “Definition and classification of chronic kidney disease” (Kidney International)
• KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of CKD